The role of fatty acid amide hydrolase enzyme inhibitors in Alzheimer's disease.

Jain, Smita; Bisht, Akansha; Verma, Kanika; Negi, Swarnima; Paliwal, Sarvesh; Sharma, Swapnil

Jain, Smita; Bisht, Akansha; Verma, Kanika; Negi, Swarnima; Paliwal, Sarvesh; Sharma, Swapnil.

Afiliación

Jain S; Department of Pharmacy, Banasthali Vidyapith, Banasthali, India.
Bisht A; Department of Pharmacy, Banasthali Vidyapith, Banasthali, India.
Verma K; Department of Pharmacy, Banasthali Vidyapith, Banasthali, India.
Negi S; Department of Pharmacy, Banasthali Vidyapith, Banasthali, India.
Paliwal S; Department of Pharmacy, Banasthali Vidyapith, Banasthali, India.
Sharma S; Department of Pharmacy, Banasthali Vidyapith, Banasthali, India.

Cell Biochem Funct ; 40(2): 106-117, 2022 Mar.

Article en En | MEDLINE | ID: mdl-34931308

Asunto(s)

Enfermedad de Alzheimer; Enfermedad de Alzheimer/tratamiento farmacológico; Amidohidrolasas/metabolismo; Inhibidores Enzimáticos/farmacología; Inhibidores Enzimáticos/uso terapéutico; Humanos; Memoria

Palabras clave

Alzheimer's disease; cognition; fatty acid amide hydrolase; neuroinflammation; synaptic plasticity

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article